欢迎来到天天文库
浏览记录
ID:55319800
大小:843.16 KB
页数:4页
时间:2020-05-14
《绝经前甲亢患者血OPG和RANKL水平变化及其与骨质疏松的关系.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第36卷第4期安徽医学2015年4月AnhuiMedicalJournal433绝经前甲亢患者血OPG和RANKL水平变化及其与骨质疏松的关系薛丽萍胡红琳夏莉王长江[摘要]目的测定绝经前弥漫性毒性甲状腺肿(甲亢)患者血清护骨素(OPG)、细胞核因子κB受体活化因子配基(RANKL)水平,了解其与骨质疏松的关系。方法选择40例绝经前甲亢患者为甲亢组,44例年龄匹配的绝经前健康女性为对照组。采用ELISA法测定受试者血清OPG和RANKL水平。采用双能X线骨密度吸收仪测定其腰椎(L24)、股骨颈、Ward三角和大
2、粗隆区骨密度。结果与对照组比较,甲亢组血OPG和RANKL水平高于对照组,差异有统计学意义(P<005),OPG/RANKL水平低于对照组(P<005)。甲亢组血OPG、RANKL与骨密度呈负相关(P值均<005)。结论绝经前女性甲亢患者血OPG、RANKL水平升高,且其变化与骨代谢有关。[关键词]护骨素;细胞核因子κB受体活化因子配基;弥漫性毒性甲状腺肿;骨质疏松doi:10.3969/j.issn.1000-0399.2015.04.014AlterationofserousOPGandRANKLin
3、premenopausalpatientswithhyperthyroidismandtheirassociationwithosteoporosisXueLiping,HuHonglin,XiaLi,etalDepartmentofEndocrinology,theFirstAffiliatedHospitalofAnhuiMedicalUniversity,Hefei230032,China[Abstract]ObjectiveTodeterminethelevelsofOPGandRANKLinseraa
4、ndtheirassociationwithosteoporosisinpremenopausalpatientswithhyperthyroidism.MethodsSeraweretakenfrom40premenopausalpatientswithhyperthyroidism,theexperimentalgroup,and44agematchedhealthyfemaleindividuals,thecontrolgroup,followedbyELISAtomeasurelevelsofOPGa
5、ndRANKLinsera.Bonemineraldensity(BMD)oflumbarvertebrae(L2-4),femoralneck,wardtriangleandtrochantermajorweremeasuredbydualenergyXrayabsorptiometry.ResultsComparedwithnormalcontrols,anotableincreaseinthelevelsofserumOPGandRANK,andasignificantdecreaseinthera
6、tioofOPG/RANKLwereobserved.CorrelationanalysisshowedthatbothOPGandRANKLwerecorrelatedwithBMDnegatively(P<005).ConclusionWehavefoundthatthereisanincreaseinthelevelsofOPGandRANKLinseraofpremenopausalpatientswithhyperthyroidism,whichiscloselyrelatedtobonemeta
7、bolism.[Keywords]Osteoprotegerin;ReceptoractivatorofnuclearfactorκBligand;Hyperthyroidism;Osteoporosis弥漫性毒性甲状腺肿(甲亢)患者可因分泌过多标准:患者均有明显的高代谢症状,甲状腺功能、甲状的甲状腺激素影响骨代谢导致骨量减少乃至骨质疏腺摄碘率及B超结果均符合Graves病性甲亢诊断;排松。OPG/RANK/RANKL被认为是调控骨代谢的重要除标准:毒性结节性甲状腺肿、垂体性甲亢等其他原因[1]信号传导通路,
8、其中细胞核因子κB受体活化因子所致甲状腺毒症,合并骨代谢异常的慢性疾病如糖尿配基(receptoractivatorofnuclearfactorκBligand,病,服用钙剂、糖皮质激素或其他影响骨代谢的药物应RANKL)是目前发现的唯一可诱导破骨细胞分化发育用史等患者。选择在我院接受体检的44例甲状腺功及发挥功能的因子。本文通过测定绝经前甲亢和健康能正常的健康绝经前女性为对照组,
此文档下载收益归作者所有